{
    "Trade/Device Name(s)": [
        "Activated Aspartate Aminotransferase",
        "Activated AST",
        "Next Generation Activated Aspartate Aminotransferase Assay"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K071525",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981221"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CIT"
    ],
    "Summary Letter Date": "March 19, 2008",
    "Summary Letter Received Date": "March 11, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1100"
    ],
    "Regulation Name(s)": [
        "Aspartate amino transferase (AST/SGOT) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Aspartate aminotransferase (AST)",
        "Serum glutamic oxaloacetic transferase (SGOT)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Abbott AEROSET System",
        "ARCHITECT c8000 System",
        "ARCHITECT c16000 System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic rate method (measurement of NADH oxidation)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott Laboratories Activated Aspartate Aminotransferase (AST/SGOT) assay for quantitation of AST in serum and plasma using enzymatic rate method on multiple Abbott platforms.",
    "Indications for Use Summary": "Device intended to measure aspartate aminotransferase (AST/SGOT) enzyme activity in serum and plasma for diagnosis and treatment of certain types of liver and heart disease.",
    "fda_folder": "Clinical Chemistry"
}